Showing results (3481-3490 of 6,791) with videos related to

Sort By:
Pageof 680
The Journal of Antibiotics|April 23, 2022
Combination effect of epsilon-poly-L-lysine and antibiotics against common bacterial pathogensSneha Sundaran, Li-Ching Kok, Hwan-You Chang
The Journal of Antibiotics|February 1, 1979
Mammalian and microbial cell-free conversion of anthracycline antibiotics and analogsP W Rueckert, P F Wiley, J P McGovren, et al.
The Journal of Antibiotics|January 29, 2022
A new metabolite, mannogeranylnerol, specifically produced at body temperature by Schizophyllum commune, a causative fungus of human mycosisShing Yiu Tam, Kenichi Uchida, Hirofumi Enomoto, et al.
The Journal of Antibiotics|August 1, 1986
Further studies on the biosynthesis of chlorothricinJ J Lee, J P Lee, P J Keller, et al.
The Journal of Antibiotics|March 25, 2022
Metabolic response of Lactobacillus acidophilus exposed to amoxicillinYue Guo, Xi Liu, Huimin Huang, et al.
The Journal of Antibiotics|January 26, 2022
Prevalence of polymyxin resistance through the food chain, the global crisisMousumi Ray, Ashwini Manjunath, Prakash M Halami
The Journal of Antibiotics|July 12, 2019
Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screeningEdyta M Grzelak, Mary P Choules, Wei Gao, et al.
The Journal of Antibiotics|July 4, 2019
Two new secondary metabolites from a mangrove-derived fungus Cladosporium sp. JS1-2Meng Bai, Cai-Juan Zheng, De-Qing Tang, et al.
The Journal of Antibiotics|July 1, 1987
Chloropolysporins A, B and C, novel glycopeptide antibiotics from Faenia interjecta sp. nov. IV. Partially deglycosylated derivativesT Takatsu, S Takahashi, Y Takamatsu, et al.
The Journal of Antibiotics|January 1, 1987
The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteriaH Irschik, R Jansen, K Gerth, et al.
Pageof 680